Skip to main content
. 2020 Jul 21;32(3):107920. doi: 10.1016/j.celrep.2020.107920

Figure 3.

Figure 3

Humoral Response to LyssaVax

(A) Schematic timeline of immunization (green syringe), sera collection (red drop), and challenge (orange bolt) through necropsy (NEC).

(B and C) Development of antibodies over time in groups of mice (n = 10 mice per group, analyzed in triplicate, mean ± SD) immunized three times with either LyssaVax (purple), rRABV (blue), or rMOKV (red). Graphs compare half-maximal responses (EC50s) between sera from immune mice probed against RABV G (B) or MOKV G (C) antigens in ELISA format. Day 0 samples did not seroconvert, so EC50 values were not calculated. Analysis within time points by Kruskal-Wallis test and Dunn’s multiple comparisons test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 for adjusted p values; n.s. is not significant).

See also Figure S5.